The following discussion and analysis of our financial condition and results of operations should be read in conjunction with our Consolidated Financial Statements and the accompanying notes... | November 16, 2022
Source: marketscreener.com
Page 29 - Development Expense News Today : Breaking News, Live Updates & Top Stories | Vimarsana
Stay updated with breaking news from Development Expense. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Top News In Development Expense Today - Breaking & Trending Today
Investegate |Nyxoah Announcements | Nyxoah: Nyxoah Reports Third Quarter 2022 Financial and Operating Results
Investegate announcements from Nyxoah, Nyxoah Reports Third Quarter 2022 Financial and Operating Results
Source: investegate.co.uk
Invitae Reports Third Quarter 2022 Financial Results
— Continued to execute against realignment plan and portfolio optimization initiatives — — Reported revenue of $133.5 million, a 16.7% YoY increase — — Cash,...
Source: prnewswire.com
Puma Biotechnology Reports Third Quarter 2022 Financial Results
Raises FY 2022 NERLYNX Net Product Revenue GuidanceLOS ANGELES--(BUSINESS WIRE)--Puma Biotechnology, Inc. (NASDAQ: PBYI), a biopharmaceutical company, announced financial results for the third quarter ended September 30, 2022. Unless otherwise stated, all comparisons are for the third quarter of 2022 compared to the...
Source: pharmiweb.com
This report contains certain estimates and forward-looking statements within the meaning of Section 21E of the Securities Exchange Act of 1934, as amended, and Section 27A of the Securities Act of... | November 4, 2022
Source: marketscreener.com